Showing results (351-360 of 440) with videos related to

Sort By:
Pageof 44
ACS Omega|September 2, 2025
Ag Nanoparticle Layer on PEDOT:PSS with Optimized Energy Levels for Improving PM6:Y6-Based Organic PhotovoltaicsAnderson E X Gavim, Yosthyn M A Florez, Patrick R Zilz, et al.
Molecular Oncology|December 17, 2021
Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastomaEduarda P Martins, Céline S Gonçalves, Marta Pojo, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|November 21, 2007
Epinephrine concentration (1:100,000 or 1:200,000) does not affect the clinical efficacy of 4% articaine for lower third molar removal: a double-blind, randomized, crossover studyCarlos F Santos, Karin C S Modena, Fernando P M Giglio, et al.
Journal of Molecular Evolution|August 27, 2025
Gene-Specific Substitution Rates for the Vespertilionidae (Chiroptera: Mammalia) Mitochondrial Genome, with the Description of Three new MitogenomesM S Borges, M M A Salles, E F Oliveira, et al.
Beneficial Microbes|April 11, 2018
Oral administration of Simbioflora® (synbiotic) attenuates intestinal damage in a mouse model of 5-fluorouracil-induced mucositisL M Trindade, V D Martins, N M Rodrigues, et al.
NPJ Precision Oncology|May 6, 2025
Immunotherapy in lung cancer brain metastasesEunice Paisana, Rita Cascão, Magda Alvoeiro, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|May 6, 2008
[The seroprevalence of HCV in patients submitted to hemodialysis and health professionals in the State of Minas Gerais, southwest of Brazil]J M M Oliveira Penido, W T Caiaffa, M Guimarães Penido, et al.
Regulatory Toxicology and Pharmacology : RTP|June 9, 2016
A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing - Operational considerationsEileen P Hayes, Robert A Jolly, Ellen C Faria, et al.
International Journal of Oral and Maxillofacial Surgery|December 15, 2010
Comparison of oral versus sublingual piroxicam during postoperative pain management after lower third molar extractionP A K Trindade, F P M Giglio, B L Colombini-Ishikiriama, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|June 27, 2012
Sublingual ketorolac and sublingual piroxicam are equally effective for postoperative pain, trismus, and swelling management in lower third molar removalPaulo A K Trindade, Fernando P M Giglio, Bella L Colombini-Ishikiriama, et al.
Pageof 44